ARTICLE | Clinical News
Aflunov regulatory update
April 25, 2011 7:00 AM UTC
In November, the European Commission approved Aflunov vaccine from Novartis to prevent influenza A (H5N1) virus infection in adults. In 2008, Novartis withdrew an MAA for the adjuvanted pre- pandemic ...